| 000 | 01390 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512202658.0 | ||
| 264 | 0 | _c19821218 | |
| 008 | 198212s 0 0 eng d | ||
| 022 | _a0002-9335 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJames, K | |
| 245 | 0 | 0 |
_aComplement: activation, consequences, and control. _h[electronic resource] |
| 260 |
_bThe American journal of medical technology _cSep 1982 |
||
| 300 |
_a735-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aCarrier Proteins _xpharmacology |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 |
_aComplement C1 Inactivator Proteins _xpharmacology |
| 650 | 0 | 4 |
_aComplement C3 _xmetabolism |
| 650 | 0 | 4 |
_aComplement C3 Nephritic Factor _xpharmacology |
| 650 | 0 | 4 |
_aComplement C3b Inactivator Proteins _xpharmacology |
| 650 | 0 | 4 |
_aComplement C5 _xmetabolism |
| 650 | 0 | 4 | _aComplement Factor H |
| 650 | 0 | 4 | _aComplement Inactivator Proteins |
| 650 | 0 | 4 | _aComplement Membrane Attack Complex |
| 650 | 0 | 4 | _aComplement Pathway, Alternative |
| 650 | 0 | 4 | _aComplement Pathway, Classical |
| 650 | 0 | 4 |
_aComplement System Proteins _xmetabolism |
| 650 | 0 | 4 | _aHemolysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntegrin alphaXbeta2 |
| 650 | 0 | 4 |
_aProperdin _xpharmacology |
| 773 | 0 |
_tThe American journal of medical technology _gvol. 48 _gno. 9 _gp. 735-42 |
|
| 999 |
_c6215879 _d6215879 |
||